Clinical Trials Browser

Phase 1/2 × INDUSTRY × EBC-46 × Clear all

NCT04834973 2023-04-18

A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma

Phase 1/2 Terminated

Melanoma